Your browser doesn't support javascript.
Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge.
Raman, Betty; Cassar, Mark Philip; Tunnicliffe, Elizabeth M; Filippini, Nicola; Griffanti, Ludovica; Alfaro-Almagro, Fidel; Okell, Thomas; Sheerin, Fintan; Xie, Cheng; Mahmod, Masliza; Mózes, Ferenc E; Lewandowski, Adam J; Ohuma, Eric O; Holdsworth, David; Lamlum, Hanan; Woodman, Myles J; Krasopoulos, Catherine; Mills, Rebecca; McConnell, Flora A Kennedy; Wang, Chaoyue; Arthofer, Christoph; Lange, Frederik J; Andersson, Jesper; Jenkinson, Mark; Antoniades, Charalambos; Channon, Keith M; Shanmuganathan, Mayooran; Ferreira, Vanessa M; Piechnik, Stefan K; Klenerman, Paul; Brightling, Christopher; Talbot, Nick P; Petousi, Nayia; Rahman, Najib M; Ho, Ling-Pei; Saunders, Kate; Geddes, John R; Harrison, Paul J; Pattinson, Kyle; Rowland, Matthew J; Angus, Brian J; Gleeson, Fergus; Pavlides, Michael; Koychev, Ivan; Miller, Karla L; Mackay, Clare; Jezzard, Peter; Smith, Stephen M; Neubauer, Stefan.
  • Raman B; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Cassar MP; Radcliffe Department of Medicine, British Heart Foundation Centre for Research Excellence, University of Oxford, Oxford, United Kingdom.
  • Tunnicliffe EM; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Filippini N; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Griffanti L; Wellcome Centre for Integrative Neuroimaging, Oxford Centre for Human Brain Activity, Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
  • Alfaro-Almagro F; Wellcome Centre for Integrative Neuroimaging, Oxford Centre for Human Brain Activity, Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
  • Okell T; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Sheerin F; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Xie C; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Mahmod M; Department of Radiology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Mózes FE; Department of Radiology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Lewandowski AJ; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Ohuma EO; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Holdsworth D; Oxford Centre for Clinical Magnetic Resonance Research, Radcliffe Department of Medicine, John Radcliffe Hospital Oxford, University of Oxford, Oxford, United Kingdom.
  • Lamlum H; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Woodman MJ; Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.
  • Krasopoulos C; Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
  • Mills R; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • McConnell FAK; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Wang C; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Arthofer C; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Lange FJ; Division of Clinical Neuroscience, Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, United Kingdom.
  • Andersson J; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Jenkinson M; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Antoniades C; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Channon KM; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Shanmuganathan M; Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Ferreira VM; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Piechnik SK; Radcliffe Department of Medicine, British Heart Foundation Centre for Research Excellence, University of Oxford, Oxford, United Kingdom.
  • Klenerman P; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Brightling C; Radcliffe Department of Medicine, British Heart Foundation Centre for Research Excellence, University of Oxford, Oxford, United Kingdom.
  • Talbot NP; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Petousi N; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Rahman NM; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Ho LP; Nuffield Department of Medicine, NIHR Oxford BRC, University of Oxford, Oxford, United Kingdom.
  • Saunders K; Institute for Lung Health, Department of Respiratory Sciences, NIHR Leicester BRC, University of Leicester, Leicester, United Kingdom.
  • Geddes JR; Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
  • Harrison PJ; Nuffield Department of Medicine, NIHR Oxford BRC, University of Oxford, Oxford, United Kingdom.
  • Pattinson K; Nuffield Department of Medicine, NIHR Oxford BRC, University of Oxford, Oxford, United Kingdom.
  • Rowland MJ; Weatherall Institute of Molecular Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Angus BJ; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
  • Gleeson F; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
  • Pavlides M; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
  • Koychev I; Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom.
  • Miller KL; Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom.
  • Mackay C; Experimental Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Jezzard P; Department of Oncology, Medical Science Department, University of Oxford, Oxford, United Kingdom.
  • Smith SM; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
  • Neubauer S; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
EClinicalMedicine ; 31: 100683, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1291524
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

BACKGROUND:

The medium-term effects of Coronavirus disease (COVID-19) on organ health, exercise capacity, cognition, quality of life and mental health are poorly understood.

METHODS:

Fifty-eight COVID-19 patients post-hospital discharge and 30 age, sex, body mass index comorbidity-matched controls were enrolled for multiorgan (brain, lungs, heart, liver and kidneys) magnetic resonance imaging (MRI), spirometry, six-minute walk test, cardiopulmonary exercise test (CPET), quality of life, cognitive and mental health assessments.

FINDINGS:

At 2-3 months from disease-onset, 64% of patients experienced breathlessness and 55% reported fatigue. On MRI, abnormalities were seen in lungs (60%), heart (26%), liver (10%) and kidneys (29%). Patients exhibited changes in the thalamus, posterior thalamic radiations and sagittal stratum on brain MRI and demonstrated impaired cognitive performance, specifically in the executive and visuospatial domains. Exercise tolerance (maximal oxygen consumption and ventilatory efficiency on CPET) and six-minute walk distance were significantly reduced. The extent of extra-pulmonary MRI abnormalities and exercise intolerance correlated with serum markers of inflammation and acute illness severity. Patients had a higher burden of self-reported symptoms of depression and experienced significant impairment in all domains of quality of life compared to controls (p<0.0001 to 0.044).

INTERPRETATION:

A significant proportion of patients discharged from hospital reported symptoms of breathlessness, fatigue, depression and had limited exercise capacity. Persistent lung and extra-pulmonary organ MRI findings are common in patients and linked to inflammation and severity of acute illness.

FUNDING:

NIHR Oxford and Oxford Health Biomedical Research Centres, British Heart Foundation Centre for Research Excellence, UKRI, Wellcome Trust, British Heart Foundation.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Topics: Long Covid Language: English Journal: EClinicalMedicine Year: 2021 Document Type: Article Affiliation country: J.eclinm.2020.100683

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Topics: Long Covid Language: English Journal: EClinicalMedicine Year: 2021 Document Type: Article Affiliation country: J.eclinm.2020.100683